Profil
Scott Lipman is currently the Chief of Staff at Turning Point Therapeutics, Inc. He started this position in 2021.
Prior to his current role, he has an undergraduate degree from the University of California, Los Angeles.
He also holds an MBA from the Kellogg School of Management.
Aktive Positionen von Scott Lipman
| Unternehmen | Position | Beginn |
|---|---|---|
| TURG POIN | Personalreferent | 08.11.2021 |
Ausbildung von Scott Lipman
| University of California, Los Angeles | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
